- Image
Location: Athens, Attica | Year of establishment: 2013
BIOEMTECH is a high-tech company that offers innovative and at the same time affordable services and products in pharmaceutical and medical research. The company has developed an in vivo animal imaging platform aimed at understanding the molecular mechanisms of living organisms. BIOEMTECH's vision is to change the way pharmaceutical research is carried out, to accelerate it and to offer innovative, everyday tools in the preclinical research field for the evaluation of new radiopharmaceuticals and the study of nanoparticles. The company provides specialized knowledge in the design of Monte Carlo simulations and the development of Machine Learning (Artificial Intelligence) algorithms.
BIOEMTECH's laboratory facilities are located at NCSR Demokritos and at the company's main building in Gerakas, Attica and include infrastructure for in vitro, radiochemistry, toxicology and in vivo imaging studies with SPECT, PET, CT and Optical systems.
BIOEMTECH has a staff of 50 people with expertise in various fields such as biotechnology, bioinformatics, radiophysics, biology, engineering, radiochemistry. The company was founded in 2013 and until today has participated in 9 H2020, 4 ERANET, 2 FORTISSIMO, 1 COST Action and 3 NSRF funded research programs, while it is an official member of the international networks ETPN, OpenGATE, EARA and the national clusters HBio and HDHC.